Title Date Topic Engagement News Relevance
Early prone positioning does not improve the outcome of patients with mild pneumonia due to SARS-CoV-2: results from an open-label, randomized controlled trial (the EPCoT Study)

Miriam Fezzi et al in medRxiv : the preprint server for health sciences

Source crossref_works_2020_03_25 Preprint
Nov 14, 2022 Placebo-controlled & Randomized 0 0 0.4
Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial

Motlabur Rahman et al in plos one (3.24)

Source crossref_works_2020_03_25
Nov 16, 2022 Placebo-controlled & Randomized 0 0 0.3
Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study

Junko Terada-Hirashima et al in jmir research protocols

Source crossref_works_2020_03_25
Nov 16, 2022 Placebo-controlled & Randomized 0 0 0.4
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

Meg J Jardine et al in bmj

Source crossref_works_2020_03_25
Nov 16, 2022 Placebo-controlled & Randomized 0 0 0.3
Prospective, randomised, parallel-group, open-label study to evaluate the effectiveness and safety of IMU-838, in combination with oseltamivir, in adults with COVID-19: theIONICtrial protocol

Kavi Sharma et al in bmj open (2.692)

Source crossref_works_2020_03_25
Nov 17, 2022 Placebo-controlled & Randomized 0 0 0.3
A randomized controlled trial of adjuvant inhalable sodium bicarbonate role in treatment of COVID-19

Mohammad El-Badrawy et al in None

Source crossref_works_2020_03_25
Nov 18, 2022 Placebo-controlled & Randomized 0 0 0.3
Early Negativization of SARS-CoV-2 Infection by Nasal Spray of Seawater plus Additives: The RENAISSANCE Open-Label Controlled Clinical Trial

Luca Cegolon et al in pharmaceutics (6.321)

Source crossref_works_2020_03_25
Nov 18, 2022 Placebo-controlled & Randomized 0 0 0.4
Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial

Mohamed Abdel-Salam Elgohary et al in journal of medicine and life

Source crossref_works_2020_03_25
Nov 19, 2022 Placebo-controlled & Randomized 0 0 0.3
Serial Viral Load Analysis by Ddpcr to Evaluate Fnc Efficacy and Safety in the Treatment of Mild Cases of Covid-19

Paula Cabral et al in None

Source crossref_works_2020_03_25
Nov 21, 2022 Placebo-controlled & Randomized 0 0 0.3
Serial Viral Load Analysis by Ddpcr to Evaluate Fnc Efficacy and Safety in the Treatment of Moderate Cases of Covid-19

Paula Cabral et al in None

Source crossref_works_2020_03_25
Nov 21, 2022 Placebo-controlled & Randomized 0 0 0.4